ClinicalTrials.Veeva

Menu

Dexamethasone Reduces Postoperative Emesis by Decreasing PGF2α and LTC4 Levels

M

Marmara University

Status

Unknown

Conditions

Breast Cancer
Thyroid Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT01811199
09.2011.0024

Details and patient eligibility

About

Hypothesis: Dexamethasone reduces postoperative emesis in thyroidectomy and mastectomy patients.

Full description

This study has been done to further study the effectiveness of dexamethasone in the prevention of postoperative emesis after breast and thyroid surgery and at the same time, the mechanism of action was investigated. In this prospective, randomized controlled trial it was hypothesized that corticosteroids exert their antiemetic effects in postoperative period via plasma prostaglandin F2 alpha (PGF2 α) and plasma leukotriene C4 (LTC4) inhibition.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • breast and thyroid cancer patients no neoadjuvant treated no NSAID or steroid usage heallthy volunteers, signed the informed consent

Exclusion criteria

  • ones who did not sign the consent form NSAID or steroid users

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems